Evidence map›Paper›PMID 27889857›Full record

ArticleJournal of mammary gland biology and neoplasia2017

Accurate Control of 17β-Estradiol Long-Term Release Increases Reliability and Reproducibility of Preclinical Animal Studies.

Céline Gérard, Anne Gallez, Charline Dubois, Pierre Drion, Philippe Delahaut, Etienne Quertemont, Agnès Noël, Christel Pequeux

Abstract read
In one paragraph

Article in Journal of mammary gland biology and neoplasia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Estrogen alleviates acute and chronic itch in mice.Experimental and therapeutic medicine · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Céline GérardLaboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege, CHU-B23, Hippocrate avenue 13, B-4000, Liège, Belgium.
Anne GallezLaboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege, CHU-B23, Hippocrate avenue 13, B-4000, Liège, Belgium.
Charline DuboisLaboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege, CHU-B23, Hippocrate avenue 13, B-4000, Liège, Belgium.
Pierre DrionExperimental Surgery unit, GIGA & Credec, University of Liege, 4000, Liège, Belgium.
Philippe DelahautCER Groupe, Health Department, 6900, Marloie, Belgium.
Etienne QuertemontDepartment of Psychology, Cognition and Behavior, University of Liege, 4000, Liège, Belgium.
Agnès NoëlLaboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege, CHU-B23, Hippocrate avenue 13, B-4000, Liège, Belgium.
Christel PequeuxLaboratory of Tumor and Development Biology, GIGA-Cancer, University of Liege, CHU-B23, Hippocrate avenue 13, B-4000, Liège, Belgium. C.Pequeux@ulg.ac.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Estrogens are the subject of intensive researches aiming to elucidate their mechanism of action on the various tissues they target and especially on mammary gland and breast cancer. The use of ready-to-use slow releasing devices to administer steroids, especially estrogens, to small experimental animals remains the method of choice in terms of animal well-being and of safety for both the researcher and the animal. In this study, we evaluated and compared, in vitro and in vivo, the release kinetic of estradiol (E2) over sixty days from two different slow-releasing systems: the matrix pellet (MP) and the reservoir implant (RI). We compared the impact of these systems in three E2-sensitive mouse models : mammary gland development, human MCF7 adenocarcinoma xenograft and mouse melanoma progression. The real amount of E2 that is released from both types of devices could differ from manufacturer specifications due to inadequate release for MP and initial burst effect for RI. Compared to MP, the interindividual variability was reduced with RI thanks to a superior control of the E2 release. Depending on the dose-dependent sensitivity of the physiological or pathological readout studied, this could lead to an improvement of the statistical power of in vivo experiments and thus to a reduction of the required animal number. Altogether, our data draw attention on the importance to adequately select the slow-releasing device that is the most appropriated to a specific experiment to better fulfill the 3Rs rule (Replacement, Reduction, Refinement) related to animal welfare and protection.

Indexed as

AnimalsBreast NeoplasmsCell Line, TumorEstradiolEstrogensFemaleHumansMammary Neoplasms, ExperimentalMCF-7 CellsMiceMice, Inbred C57BLMice, NudeRats, Sprague-DawleyReproducibility of ResultsEstradiolEstrogensAnimal welfareEstradiolEstrogenHormone administrationImplantMatrixMousePelletPharmacokineticsRatReservoirSlow-release

Identifiers

PMID27889857
PMCPMC5310554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.